Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs-Reference-Cited by-同舟云学术

Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs

Published:2017-10-18 Issue:1 Volume:73 Page:134-142
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Buil Jochem B^ORCID,Brüggemann Roger J M,Wasmann Roeland E,Zoll Jan,Meis Jacques F,Melchers Willem J G,Mouton Johan W,Verweij Paul E^ORCID

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/73/1/134/22755695/dkx354.pdf

Reference35 articles.

1. Current approaches to diagnosis and treatment of invasive aspergillosis;Am J Respir Crit Care Med,2006

2. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America;Clin Infect Dis,2016

3. Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents;Clin Infect Dis,2009

4. Current concepts in antifungal pharmacology;Mayo Clin Proc,2011

5. Isavuconazole: a new extended spectrum triazole for invasive mold diseases;Future Microbiol,2015

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimization of oral isavuconazole dose for population in special physiological or pathological state: a physiologically based pharmacokinetics model-informed precision dosing;Journal of Antimicrobial Chemotherapy;2024-08-01

2. Aspergillus fumigatus—a systematic review to inform the World Health Organization priority list of fungal pathogens;Medical Mycology;2024-06

3. Pharmacokinetics of isavuconazole at different target sites in healthy volunteers after single and multiple intravenous infusions;Journal of Antimicrobial Chemotherapy;2024-03-28

4. Therapeutic Updates on the Management of Tinea Corporis or Cruris in the Era of Trichophyton Indotineae;Indian Journal of Dermatology;2023-09

5. Therapeutic Drug Monitoring of Isavuconazole: Lessons Learnt from a Real-life Setting in a Tertiary Care Center in India;Indian Journal of Critical Care Medicine;2023-03-31